nitazoxanide has been researched along with Cryptosporidiosis in 96 studies
*Cryptosporidiosis: Intestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 20 (20.83) | 18.2507 |
2000's | 36 (37.50) | 29.6817 |
2010's | 24 (25.00) | 24.3611 |
2020's | 16 (16.67) | 2.80 |
Authors | Studies |
---|---|
Adagu, IS; Berry, NG; Lilian Low, AC; Moores, SL; Rossignol, JF; Row, E; Stachulski, AV; Warhurst, DC | 1 |
Chong, CR; Downey, AS; Graczyk, TK; Sullivan, DJ | 1 |
Campbell, SD; Griggs, DW; Huston, CD; Meyers, MJ; Miller, P; Oboh, E; Philo, E; Schubert, TJ; Stebbins, EE; Teixeira, JE; Thakellapalli, H | 1 |
Abdelaal, AA; Afife, AA; Badawi, MA; Fadl, HO; Fahmy, MA; Hassan, SI; Ismail, MAM; Khairy, RA; Shalaby, MA | 1 |
Caravedo, MA; White, AC | 1 |
Wang, D; Yan, Y; Yang, B; Yin, J; Zhang, Y; Zhu, G | 1 |
Li, Y; Tie, X; Xu, J; Yin, W; Zhang, Z; Zhou, R | 1 |
Abd El-Moaty, HI; Al Abdulsalam, NK; El Sherif, F; Hamad, RS | 1 |
Abd El Hameed, BH; Al-Ghandour, AMF; El Gamal, RL; El-Akabawy, N; Elbahaie, ES; Fathy, GM; Yahia, SH | 1 |
Liu, M; Wang, D; Wu, X; Yin, J; Zhang, D; Zhang, Y; Zhu, G | 1 |
El-Shafai, NM; Ghanem, NF; Helal, IB; Khaleil, SR; M El-Mehasseb, I; Mira, NM | 1 |
Abdel-Tawab, H; Ahmed, MM; El-Askary, HM; Fouad, FM; Hamdy, DA; Ismail, MAM; Mohamed, F | 1 |
Cuda, A; Pyzocha, N | 1 |
Abed, M; Eid, PS; Elhusseiny, KM; Elkolaly, SS; Hashan, MR; Huu-Hoai, L; Huy, NT; Loc, LQ; Low, SK; Minh, LHN; Nghia, TLB; Tawfik, GM; Tieu, TM; Y, MN | 1 |
Kwon, J; Stancampiano, FF | 1 |
Abdel Kader, A; El Amir, A; Farid, A; Madbouly, N; Rabee, I | 1 |
Alfandari, S; Bories, C; Boyle, EM; Caro, J; Cordier, C; Davies, FE; Demarquette, H; Demonchy, J; Escure, G; Facon, T; Faure, K; Fréalle, E; Herbaux, C; Morgan, G; Noel, MP; Van De Wyngaert, Z; Willaume, A | 1 |
Amadi, B; Ashigbie, PG; Aziz, N; Diagana, TT; Kelly, P; Manjunatha, UH; Shepherd, S; Spector, JM; Steiner, KL | 1 |
Ryan, U; Squire, SA | 1 |
El-Sayed, SH; Ismail Negm, MS; Madbouly Taha, N; Salah A Yousof, HA; Younis, AI | 1 |
Beamer, G; Campbell, MA; Girouard, D; Harwood, M; Lee, S; Meyers, MJ; Tzipori, S | 1 |
Chavez, MA; White, AC | 1 |
Humphreys, E; Motaze, NV; Nwachukwu, C | 1 |
Abaza, BE; Abdel-Hamid, MA; Farag, TI; Hamza, RS; Moustafa, RA | 1 |
Bartelt, LA; Bolick, DT; Guerrant, RL; Hoffman, PS; Huston, CD; Kolling, GL; Stebbins, E | 1 |
Dimmitt, RA; Maclin, J; Thame, KA; Vadlamudi, N | 1 |
Favennec, L; François, A; Gargala, G; Rossignol, JF | 1 |
Gutwein, MB; Kaleem, Z; Weinstock, LB | 1 |
Abdella, OH; Aboshiesha, GA; Abu-Hashim, AH; El-Bader, MM; El-Shemy, AS; Hussien, SM; Taha, MA | 1 |
Ali, S; Baqi, S; Kalam, K; Mumar, S; Raja, K | 1 |
Abou-Bacar, A; Borni-Duval, C; Brunet, J; Caillard, S; Candolfi, E; Dalle, F; Favennec, L; Lemoine, JP; Moulin, B; Muller, C; Pesson, B; Pfaff, AW; Razakandrainibe, R; Sautour, M; Valot, S | 1 |
Alcala-Canto, Y; Gutierrez, L; Moron-Soto, M; Sumano, H; Tapia, G | 1 |
Nathwani, D; Shaw, J; Smith, S | 1 |
Gargala, G | 1 |
Capparelli, EV; Syed, SS | 1 |
Abraham, DR; Cotton, MF; Rabie, H | 1 |
Deplazes, P; Hemphill, A; Kohler, L; Schnyder, M | 1 |
Bellosa, ML; Bowman, DD; Divers, TJ; Linden, TC; Nydam, DV; Ollivett, TL; Zambriski, JA | 1 |
Cabada, MM; Pantenburg, B; White, AC | 1 |
Rossignol, JF | 2 |
Bandin, F; Baudouin, V; Carol, A; Cassaing, S; Decramer, S; Garnier, A; Guigonis, V; Kwon, T; Linas, MD; Valentin, A | 1 |
Ayuo, PO | 1 |
Amadi, B; Katubulushi, M; Kelly, P; Mwiya, M; Payne, L; Sianongo, S; Watuka, A | 1 |
Cabada, MM; White, AC | 1 |
Dalle, F; Deconinck, E; Grenouillet, F; Larosa, F; Legrand, F; Millon, L; Rohrlich, PS; Saas, P | 1 |
Acikgoz, Y; Bek, K; Genc, G; Hokelek, M; Ozkaya, O; Sensoy, SG | 1 |
Kelly, P | 1 |
Costa, LB; Freire, RS; Guerrant, RL; Hoffman, PS; JohnBull, EA; Lima, AA; Oriá, RB; Reeves, JT; Roche, JK; Sevilleja, JE; Warren, CA | 1 |
Asaly, M; Cantor, R; Mackey, J; Nacca, NE | 1 |
Dauby, N; Dupont, E; Levy, J; Menotti, J; Moens, C; Robberecht, F; Talabani, H; van Gool, T; Vandenberg, O | 1 |
Amir, J; Behor, J; Cleper, R; Dagan, A; Davidovits, M; Krause, I; Samra, Z | 1 |
Abdou, AG; Afifi, AF; Elnaidany, NF; Harba, NM | 1 |
Amadi, B; Ayoub, A; Kelly, P; Musuku, J; Mwiya, M; Sianongo, S; Watuka, A | 1 |
Agnamey, P; Ballet, JJ; Brasseur, P; Favennec, L; Leméteil, D; Li, X; Rossignol, JF | 1 |
White, AC | 1 |
Okhuysen, PC; Robinson, P; White, AC | 1 |
Moustafa, MA | 1 |
Bailey, JM; Erramouspe, J | 1 |
Armson, A; Reynoldson, JA; Thompson, RC | 1 |
White, CA | 1 |
Chappell, C; Huang, DB; Okhuysen, PC | 1 |
Jenkins, MC | 1 |
Arya, R; Parashar, A | 1 |
Baishanbo, A; Ballet, JJ; Duclos, C; Favennec, L; François, A; Gargala, G; Rossignol, JF | 1 |
el-Gohary, Y; Kabil, SM; Rossignol, JF; Younis, AM | 1 |
Bandettini, R; Cappelli, B; Castagnola, E; Coccia, C; Di Martino, D; Faraci, M; Lanino, E; Moroni, C; Morreale, G; Terranova, MP | 1 |
Abubakar, I; Aliyu, SH; Arumugam, C; Hunter, PR; Usman, NK | 1 |
Ali, MA; Borum, ML; Entwisle, C; Long, SE; Orenstein, JM; Ramsay, DB; Rossi, C | 1 |
Chartier, C; Martin, J; Rocques, H; Viel, H | 1 |
Nozaki, T | 1 |
Al-Malki, JS; Sanad, MM | 1 |
Dembele, TM; Diakite, M; Diallo, DA; Doumbo, O; Pichard, E; Rossignol, JF; Traore, F; Traore, HA | 1 |
D'Onfro, J; Fairfield, A; Griffiths, JK; Theodos, CM; Tzipori, S | 1 |
Blagburn, BL; Boykin, DW; Drain, KL; Kinard, RG; Land, TM; Lindsay, DS; Moore, PH; Patrick, DA; Tidwell, RR | 1 |
Barchiesi, F; Burzacchini, F; Cirioni, O; Dini, M; Giacometti, A; Scalise, G | 1 |
Ancarani, F; Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Abdel-Maboud, AI; el-Kady, MS; Kabil, SM; Mostafa, MS; Rossignol, JF | 1 |
Smart, T | 2 |
Young, A | 1 |
Cooper, S | 1 |
James, JS | 2 |
Bornhoeft, MA | 1 |
Bowers, M | 1 |
Ayers, MS; Ayoub, A; Rossignol, JF | 1 |
Breitschwerdt, EB; Gookin, JL; Law, JM; Levy, MG; Papich, MG; Poore, MF | 1 |
17 review(s) available for nitazoxanide and Cryptosporidiosis
Article | Year |
---|---|
Effect of nitazoxanide on diarrhea: A systematic review and network meta-analysis of randomized controlled trials.
Topics: Animals; Clostridium Infections; Cryptosporidiosis; Diarrhea; Entamoebiasis; Giardia lamblia; Giardiasis; Humans; Network Meta-Analysis; Nitro Compounds; Thiazoles | 2020 |
Use-case scenarios for an anti-Cryptosporidium therapeutic.
Topics: Antiparasitic Agents; Child, Preschool; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Outbreaks; Fluid Therapy; Humans; Immunocompromised Host; Infant; Infant, Newborn; Nitro Compounds; Thiazoles | 2021 |
Cryptosporidium and Giardia in Africa: current and future challenges.
Topics: Africa; Animals; Antiprotozoal Agents; Child; Climate Change; Cost of Illness; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Management; Feces; Genotyping Techniques; Giardia; Giardiasis; Humans; Nitro Compounds; Prevalence; Public Health; Thiazoles; Zoonoses | 2017 |
Novel treatment strategies and drugs in development for cryptosporidiosis.
Topics: Animals; Antiprotozoal Agents; Clofazimine; Cryptosporidiosis; Diarrhea; Drug Development; Global Health; Humans; Immunocompromised Host; Mice; Nitro Compounds; Thiazoles | 2018 |
Treatment interventions for diarrhoea in HIV-infected and HIV-exposed children: a systematic review.
Topics: Adolescent; Anti-HIV Agents; Antiparasitic Agents; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Dietary Supplements; Drug Interactions; HIV Infections; Humans; Micronutrients; Nitro Compounds; Randomized Controlled Trials as Topic; Thiazoles | 2018 |
Drug treatment and novel drug target against Cryptosporidium.
Topics: Animals; Coccidiostats; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Outbreaks; Humans; Nitro Compounds; Thiazoles; Treatment Outcome | 2008 |
Treatment of cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiretroviral Therapy, Highly Active; Azithromycin; Biliary Tract Diseases; Coccidiostats; Cryptosporidiosis; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Rifamycins; Rifaximin; Thiazoles | 2009 |
Human cryptosporidiosis: a review.
Topics: Amebicides; Animals; Anti-Bacterial Agents; Antiparasitic Agents; Classification; Coccidiostats; Cryptosporidiosis; HIV Infections; Humans; Kenya; Nitro Compounds; Paromomycin; Prognosis; Spiramycin; Thiazoles | 2009 |
Treatment of cryptosporidiosis: do we know what we think we know?
Topics: Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium; HIV Infections; Humans; Immunocompromised Host; Molecular Epidemiology; Nitro Compounds; Thiazoles | 2010 |
Cryptosporidiosis: a rare and severe infection in a pediatric renal transplant recipient.
Topics: Child; Coccidiostats; Cryptosporidiosis; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Nitro Compounds; Paromomycin; Postoperative Complications; Spiramycin; Thiazoles | 2012 |
Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?
Topics: Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium; Diarrhea; Drinking Water; HIV Infections; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Thiazoles; Water Purification; Zambia | 2011 |
Nitazoxanide treatment for giardiasis and cryptosporidiosis in children.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Child; Clinical Trials as Topic; Cryptosporidiosis; Drug Interactions; Giardiasis; Humans; Nitro Compounds; Thiazoles | 2004 |
A review of chemotherapeutic approaches to the treatment of cryptosporidiosis.
Topics: Animals; Biogenic Polyamines; Coccidiostats; Cryptosporidiosis; Cryptosporidium; Humans; Nitro Compounds; Thiazoles; Tubulin | 2003 |
Nitazoxanide: a new broad spectrum antiparasitic agent.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Drug Approval; Giardiasis; Helminthiasis; Humans; Nitro Compounds; Protozoan Infections; Thiazoles; United States | 2004 |
Cryptosporidiosis in children.
Topics: Animals; Child, Preschool; Coccidiostats; Cryptosporidiosis; Cryptosporidium; Female; Humans; Infant; Male; Nitro Compounds; Thiazoles | 2004 |
Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis.
Topics: Anti-Retroviral Agents; Antiprotozoal Agents; Cryptosporidiosis; Diarrhea; Drug Therapy, Combination; Female; HIV Seronegativity; HIV Seropositivity; Humans; Immunocompromised Host; Male; Nitro Compounds; Opportunistic Infections; Randomized Controlled Trials as Topic; Thiazoles; Treatment Failure | 2007 |
[Attention-getting zoonoses: Cryptosporidiosis].
Topics: AIDS-Related Opportunistic Infections; Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Drug Design; Fluid Therapy; Fluorescent Antibody Technique; Humans; Molecular Diagnostic Techniques; Nitro Compounds; Thiazoles; Zoonoses | 2007 |
15 trial(s) available for nitazoxanide and Cryptosporidiosis
Article | Year |
---|---|
The controverted therapeutic efficacy of Allium sativum and Artemisia herba-alba extracts on Cryptosporidium-infected mice.
Topics: Animals; Cryptosporidiosis; Cryptosporidium; Garlic; Interferon-gamma; Male; Mice | 2023 |
ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
Topics: Antiparasitic Agents; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Female; Humans; Immunocompromised Host; Infant; Male; Nitro Compounds; Polymerase Chain Reaction; Thiazoles | 2016 |
Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children.
Topics: AIDS-Related Opportunistic Infections; Animals; Child, Preschool; Coccidiostats; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Humans; Infant; Nitro Compounds; Thiazoles | 2008 |
Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
Topics: Animals; Animals, Newborn; Antiparasitic Agents; Cattle; Cryptosporidiosis; Cryptosporidium parvum; Nitro Compounds; Thiazoles | 2009 |
Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
Topics: Animals; Animals, Newborn; Antiparasitic Agents; Cattle; Cattle Diseases; Cryptosporidiosis; Dairying; Feces; Kaplan-Meier Estimate; Male; Nitro Compounds; Oocysts; Thiazoles | 2009 |
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.
Topics: Antiparasitic Agents; Child, Preschool; Cryptosporidiosis; Double-Blind Method; Female; HIV Seropositivity; Humans; Infant; Male; Nitro Compounds; Thiazoles; Treatment Outcome; Zambia | 2009 |
Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.
Topics: Antiprotozoal Agents; Child, Preschool; Cryptosporidiosis; Diarrhea; Female; HIV Seronegativity; HIV Seropositivity; Humans; Infant; Male; Nitro Compounds; Nutritional Status; Thiazoles; Treatment Outcome; Zambia | 2002 |
Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species.
Topics: Administration, Oral; Adult; Antiparasitic Agents; Cryptosporidiosis; Diarrhea; Double-Blind Method; Enteritis; Humans; Nitro Compounds; Prospective Studies; Suspensions; Tablets; Thiazoles; Treatment Outcome | 2006 |
Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.
Topics: Adolescent; Adult; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Antiparasitic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Feces; Female; Humans; Male; Middle Aged; Nitro Compounds; Sex Distribution; Thiazoles; Time Factors; Treatment Outcome; United States | 2006 |
Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.
Topics: Animals; Animals, Newborn; Antiparasitic Agents; Cryptosporidiosis; Feces; Female; Goat Diseases; Goats; Male; Nitro Compounds; Thiazoles | 2007 |
Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Humans; Intestinal Diseases, Parasitic; Mali; Nitro Compounds; Thiazoles | 1997 |
Cryptosporidiosis in Benha, study of some recent modalities in diagnosis and treatment.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Egypt; Female; Fluorescent Antibody Technique, Direct; Humans; Infant; Male; Nitro Compounds; Prevalence; Sensitivity and Specificity; Thiazoles; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
NTZ for cryptosporidiosis.
Topics: Antiprotozoal Agents; Cryptosporidiosis; HIV Infections; Humans; Nitro Compounds; Randomized Controlled Trials as Topic; Thiazoles | 1996 |
AIDS patients sought for study with NTZ for cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Double-Blind Method; Humans; Nitro Compounds; Patient Selection; Placebos; Thiazoles | 1997 |
Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Double-Blind Method; Drug Administration Schedule; Feces; Female; Humans; Infant; Male; Middle Aged; Nitro Compounds; Prospective Studies; Thiazoles | 2001 |
64 other study(ies) available for nitazoxanide and Cryptosporidiosis
Article | Year |
---|---|
Identification of isoflavone derivatives as effective anticryptosporidial agents in vitro and in vivo.
Topics: Animals; Cattle; Cell Line, Tumor; Coccidiostats; Cryptosporidiosis; Cryptosporidium parvum; Female; Genistein; Gerbillinae; Humans; Immunocompromised Host; Isoflavones; Male; Structure-Activity Relationship | 2006 |
Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
Topics: Animals; Animals, Newborn; Antiprotozoal Agents; Cell Line; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Pyrvinium Compounds; Treatment Outcome | 2008 |
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin.
Topics: Antiprotozoal Agents; Cell Line; Cryptosporidiosis; Cryptosporidium; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2021 |
Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium; Diabetes Mellitus, Experimental; Ivermectin; Mice; Nitro Compounds; Rodent Diseases; Selenium; Thiazoles | 2021 |
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
Topics: Acquired Immunodeficiency Syndrome; Antiprotozoal Agents; Child; Child, Preschool; Cryptosporidiosis; Cryptosporidium; Diarrhea; Humans | 2023 |
On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target.
Topics: Algorithms; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cryptosporidiosis; Cryptosporidium; Cryptosporidium parvum; Humans; Paclitaxel; Parasites | 2023 |
A case of septic shock due to delayed diagnosis of Cryptosporidium infection after liver transplantation.
Topics: Antacids; Cryptosporidiosis; Cryptosporidium; Delayed Diagnosis; Diarrhea; Humans; Hypovolemia; Liver Transplantation; Male; Shock, Septic | 2023 |
Chlorogenic acid derived from Moringa oleifera leaf as a potential antiinflammatory agent against cryptosporidiosis in mice.
Topics: Animals; Anti-Inflammatory Agents; Chlorogenic Acid; Cryptosporidiosis; Cryptosporidium; Mice; Moringa oleifera | 2023 |
Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein.
Topics: Animals; Antiprotozoal Agents; Cost-Benefit Analysis; Cryptosporidiosis; Cryptosporidium; Cryptosporidium parvum; Docetaxel; Humans; Mice; Paromomycin; Plant Breeding; Vorinostat | 2023 |
Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
Topics: Animals; Cryptosporidiosis; Cryptosporidium; Cryptosporidium parvum; Mice; Oocysts; Sunlight | 2023 |
Newly fabricated zinc oxide nanoparticles loaded materials for therapeutic nano delivery in experimental cryptosporidiosis.
Topics: Animals; Cryptosporidiosis; Cryptosporidium; Humans; Mice; Nanoparticles; Zinc Oxide | 2023 |
Common Intestinal Parasites.
Topics: Aged; Albendazole; Animals; Child; Cryptosporidiosis; Cryptosporidium; Cyclosporiasis; Diarrhea; Feces; Giardiasis; Humans; Parasites | 2023 |
56-Year-Old Man With Profuse Diarrhea.
Topics: alpha 1-Antitrypsin; Colonoscopy; Cryptosporidiosis; Diagnosis, Differential; Diarrhea; Feces; Humans; Hypoalbuminemia; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nitro Compounds; Protein-Losing Enteropathies; Thiazoles; Travel | 2021 |
The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ileum; Immunocompromised Host; Immunomodulation; Male; Metronidazole; Mice; Nitro Compounds; Parasite Load; Thiazoles | 2021 |
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma.
Topics: Antiparasitic Agents; Combined Modality Therapy; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Management; Disease Susceptibility; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nitro Compounds; Retreatment; Symptom Assessment; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
Topics: Animals; Antiparasitic Agents; Atorvastatin; Colon; Cryptosporidiosis; Drug Synergism; Duodenum; Feces; Gallbladder; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Immunosuppression Therapy; Jejunum; Lung; Male; Mice; Nitro Compounds; Stomach; Tablets; Thiazoles | 2017 |
The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Disease Models, Animal; Drug Therapy, Combination; Nitro Compounds; Sus scrofa; Swine; Thiazoles; Treatment Outcome | 2017 |
Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Topics: Animals; Antiprotozoal Agents; Benzamides; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Mice, Inbred C57BL; Nitro Compounds; Pyruvate Synthase; Thiazoles; Weight Loss | 2018 |
Cryptosporidial infection in children with inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiparasitic Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cryptosporidiosis; Cryptosporidium; Diarrhea; Feces; Female; Humans; Immunosuppressive Agents; Male; Nitro Compounds; Patient Readmission; Recurrence; Retrospective Studies; Severity of Illness Index; Thiazoles | 2013 |
Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Gerbillinae; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Nitro Compounds; Thiazoles; Treatment Outcome | 2013 |
Cryptosporidiosis-associated lymphocytic colitis.
Topics: Antiparasitic Agents; Biopsy; Colitis, Lymphocytic; Colonoscopy; Cryptosporidiosis; Humans; Male; Middle Aged; Missouri; Nitro Compounds; Thiazoles | 2013 |
Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children.
Topics: Animals; Child, Preschool; Cryptosporidiosis; Female; Hospitalization; Humans; Infant; Male; Nitro Compounds; Paromomycin; Rural Population; Thiazoles; Urban Population | 2013 |
Prevalence, clinical presentation and treatment outcome of cryptosporidiosis in immunocompetent adult patients presenting with acute diarrhoea.
Topics: Acute Disease; Adult; Animals; Antiparasitic Agents; Cryptosporidiosis; Diarrhea; Female; Humans; Male; Middle Aged; Nitro Compounds; Pakistan; Prevalence; Prospective Studies; Thiazoles; Treatment Outcome | 2014 |
Ruling out nosocomial transmission of Cryptosporidium in a renal transplantation unit: case report.
Topics: Acute Kidney Injury; Adult; Animals; Coccidiostats; Cross Infection; Cryptosporidiosis; Cryptosporidium; Diarrhea; Feces; Female; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Nitro Compounds; Thiazoles | 2016 |
Efficacy of nitazoxanide to treat natural Giardia infections in dogs.
Topics: Administration, Oral; Alanine Transaminase; Animals; Antiprotozoal Agents; Aspartate Aminotransferases; Cryptosporidiosis; Cryptosporidium; Dog Diseases; Dogs; Feces; Giardia; Giardiasis; Guanidines; Humans; Nitro Compounds; Praziquantel; Pyrantel Pamoate; Thiazoles | 2017 |
Nitazoxanide for cryptosporidial infection in Crohn's disease.
Topics: Adult; Animals; Antiprotozoal Agents; Colitis; Crohn Disease; Cryptosporidiosis; Cryptosporidium parvum; Female; Humans; Intestinal Diseases, Parasitic; Nitro Compounds; Opportunistic Infections; Thiazoles | 2008 |
Nitazoxanide treatment of Cryptosporidium parvum in human immunodeficiency virus-infected children.
Topics: AIDS-Related Opportunistic Infections; Animals; Child, Preschool; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; HIV Infections; Humans; Infant; Nitro Compounds; Thiazoles | 2008 |
Cryptosporidium and Giardia: treatment options and prospects for new drugs.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiparasitic Agents; Antiretroviral Therapy, Highly Active; Azithromycin; Benzimidazoles; Cryptosporidiosis; Giardia lamblia; Giardiasis; Humans; Nitro Compounds; Nitroimidazoles; Paromomycin; Roxithromycin; Thiazoles | 2010 |
Cryptosporidiosis in paediatric renal transplantation.
Topics: Adolescent; Antiparasitic Agents; Biopsy; Child; Cohort Studies; Cryptosporidiosis; Diarrhea; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Nitro Compounds; Prednisone; Sirolimus; Tacrolimus; Thiazoles; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study.
Topics: Adult; Animals; Azithromycin; Cryptosporidiosis; Cryptosporidium parvum; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lymphopenia; Male; Middle Aged; Nitro Compounds; Thiazoles; Transplantation, Homologous; Young Adult | 2011 |
Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; DNA, Protozoan; Feces; Female; Ileum; Intestinal Mucosa; Malnutrition; Mice; Mice, Inbred C57BL; Nitro Compounds; RNA, Messenger; Thiazoles; Toll-Like Receptors; Weaning; Weight Gain | 2011 |
Nausea, vomiting, and diarrhea in a 9-year-old girl.
Topics: Antiparasitic Agents; Child; Cryptosporidiosis; Diarrhea; Feces; Female; Humans; Immunocompetence; Nausea; Nitro Compounds; Oocysts; Thiazoles; Vomiting | 2011 |
Management of a Cryptosporidium hominis outbreak in a day-care center.
Topics: Animals; Antiparasitic Agents; Belgium; Child Day Care Centers; Child, Preschool; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Outbreaks; Feces; Female; Humans; Hygiene; Infant; Infection Control; Male; Nitro Compounds; Paromomycin; Polymerase Chain Reaction; Thiazoles | 2012 |
Cryptosporidiosis in children following solid organ transplantation.
Topics: Antiparasitic Agents; Child; Child, Preschool; Cryptosporidiosis; Fluid Therapy; Humans; Nitro Compounds; Organ Transplantation; Thiazoles | 2012 |
Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Cyclin D1; Disease Models, Animal; Female; Immunocompromised Host; Intestinal Mucosa; Intestines; Liver; Mice; Nitro Compounds; Oocysts; Thiazoles | 2013 |
Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
Topics: Adenosine; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Feces; Immunocompromised Host; Male; Nitro Compounds; Parasite Egg Count; Paromomycin; Rats; Rats, Sprague-Dawley; Thiazoles | 2003 |
Nitazoxanide: an important advance in anti-parasitic therapy.
Topics: Antiparasitic Agents; Cryptosporidiosis; Giardiasis; Helminthiasis; Humans; Intestinal Diseases, Parasitic; Nitro Compounds; Thiazoles | 2003 |
Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis.
Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium; Humans; Immunologic Techniques; Nitro Compounds; Thiazoles | 2003 |
Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Topics: Animals; Animals, Suckling; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Immunocompromised Host; Mice; Nitro Compounds; Thiazoles; Wheat Germ Agglutinins | 2003 |
Present and future control of cryptosporidiosis in humans and animals.
Topics: Animals; Antiparasitic Agents; Cattle; Cattle Diseases; Colostrum; Cryptosporidiosis; Cryptosporidium parvum; Female; Humans; Immunization, Passive; Nitro Compounds; Pregnancy; Protozoan Proteins; Protozoan Vaccines; Thiazoles; Vaccines, Attenuated; Water | 2004 |
Nitazoxanide.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Giardia lamblia; Giardiasis; Humans; Nitro Compounds; Thiazoles | 2005 |
Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
Topics: Amebicides; Animals; Antiprotozoal Agents; Biliary Tract Diseases; Cattle; Cryptosporidiosis; Cryptosporidium parvum; Dexamethasone; Feces; Gallbladder; Gerbillinae; Ileum; Immunosuppression Therapy; Immunosuppressive Agents; Nitro Compounds; Paromomycin; Thiazoles | 2006 |
Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant?
Topics: Animals; Antigens, CD; Antiparasitic Agents; Biopsy; CD3 Complex; CD4-Positive T-Lymphocytes; Child; Colon; Cryptosporidiosis; Cryptosporidium; Humans; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Male; Nitro Compounds; Stem Cell Transplantation; Thiazoles; Transplantation, Homologous | 2007 |
Isolated gastric cryptosporidiosis in an immunocompetent patient.
Topics: Aged, 80 and over; Animals; Antiparasitic Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Chronic Disease; Cryptosporidiosis; Cryptosporidium parvum; Humans; Immunocompetence; Male; Nitro Compounds; Prednisolone; Stomach; Thiazoles; Treatment Outcome | 2007 |
Immunochemotherapy for cryptosporidiosis in immunosuppressed mouse model.
Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunotherapy; Interferon-gamma; Life Cycle Stages; Mice; Nitro Compounds; Oocysts; Parasite Egg Count; Paromomycin; Random Allocation; Thiazoles; Time Factors; Treatment Outcome | 2007 |
Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Male; Mice; Mice, SCID; Nitro Compounds; Rabbits; Swine; Thiazoles | 1998 |
Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.
Topics: Animals; Animals, Newborn; Antiprotozoal Agents; Cryptosporidiosis; Dose-Response Relationship, Drug; Mice; Mice, Inbred ICR; Nitro Compounds; Paromomycin; Thiazoles | 1998 |
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Drug Therapy, Combination; Feces; Female; Humans; Nitro Compounds; Paromomycin; Thiazoles; Treatment Outcome | 1999 |
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cell Survival; Cells, Cultured; Cryptosporidiosis; Cryptosporidium parvum; Humans; Nitro Compounds; Rifabutin; Thiazoles | 2000 |
Cryptosporidium clinical trial started.
Topics: AIDS-Related Opportunistic Infections; Anticestodal Agents; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Humans; Nitro Compounds; Thiazoles | 1995 |
Orphan drug designation for NTZ expanded.
Topics: AIDS-Related Opportunistic Infections; Antioxidants; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Drug Approval; Humans; Immunocompromised Host; Nitro Compounds; Thiazoles; United States; United States Food and Drug Administration | 1997 |
NTZ trials for cryptosporidiosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anticestodal Agents; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Diarrhea; Humans; Nitro Compounds; Thiazoles | 1995 |
New treatment for cryptosporidiosis.
Topics: Abdominal Pain; Anticestodal Agents; Cryptosporidiosis; Diarrhea; Humans; Nitro Compounds; Thiazoles | 1995 |
Speaking of the runs.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Humans; Microsporida; Microsporidiosis; Nitro Compounds; Thiazoles | 1996 |
Expanded access and expanded trials.
Topics: Anticestodal Agents; Cryptosporidiosis; Drug Approval; HIV Infections; Humans; Nitro Compounds; Thiazoles | 1996 |
Cryptosporidiosis: NTZ available at buyers' club; customs holds 2nd shipment.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Humans; Nitro Compounds; Thiazoles | 1996 |
Incoming NTZ blocked by US customs. People With AIDS Health Group.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Drug and Narcotic Control; Humans; Nitro Compounds; Thiazoles; United States | 1996 |
NTZ--we got it.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Diarrhea; Humans; Mexico; Nitro Compounds; Thiazoles | 1996 |
NTZ for cryptosporidiosis: larger expanded access; buyers' club/FDA conflict. Food and Drug Administration.
Topics: Altruism; Clinical Trials as Topic; Consumer Organizations; Cryptosporidiosis; Drug Industry; Drugs, Investigational; Health Services Accessibility; Humans; Nitro Compounds; Thiazoles; Triazoles; United States; United States Food and Drug Administration | 1996 |
NTZ submitted to FDA for cryptosporidiosis. Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Antioxidants; Cryptosporidiosis; Drug Approval; Humans; Nitro Compounds; Thiazoles; United States; United States Food and Drug Administration | 1998 |
Cryptosporidiosis gets a new treatment.
Topics: AIDS-Related Opportunistic Infections; Antiparasitic Agents; Cryptosporidiosis; Diarrhea; Humans; Nitro Compounds; Thiazoles | 1998 |
Nitazoxanide for cryptosporidial diarrhea.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Drug Therapy, Combination; Health Services Accessibility; Humans; Nitro Compounds; Risk Factors; Thiazoles | 1998 |
NTZ: advisory committee votes against approval.
Topics: Acquired Immunodeficiency Syndrome; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Diarrhea; Drug Approval; Health Services Accessibility; Humans; Nitro Compounds; Thiazoles; United States; United States Food and Drug Administration | 1998 |
Experimental infection of cats with Tritrichomonas foetus.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Cat Diseases; Cats; Cryptosporidiosis; Cryptosporidium; Diarrhea; Feces; Female; Intestinal Diseases; Intestinal Mucosa; Nitro Compounds; Parasite Egg Count; Prednisolone; Protozoan Infections; Protozoan Infections, Animal; Specific Pathogen-Free Organisms; Thiazoles; Tritrichomonas foetus | 2001 |